Sheaff Brock Investment Advisors, LLC Amgen Inc Transaction History

Sheaff Brock Investment Advisors, LLC

$1.07 Billion
Q2 2024

A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 1,837 shares of AMGN stock, worth $591,899. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,837

Previous 3,073 40.22%

Holding current value

$591,899

Previous $873,000 34.36%

% of portfolio

0.05%

Previous 0.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $324,759 - $394,667	-1,236 Reduced 40.22%	1,837 $573,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $268 - $324	1 Added 0.03%	3,073 $873,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $3,324 - $3,749	-13 Reduced 0.42%	3,072 $884,000
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $1,530 - $1,900	7 Added 0.23%	3,085 $829,000
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $2.93 Million - $3.47 Million	-13,690 Reduced 81.64%	3,078 $683,000
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $126,216 - $153,836	559 Added 3.45%	16,768 $4.05 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2.86 Million - $3.63 Million	12,477 Added 334.32%	16,209 $4.26 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $7,182 - $8,100	32 Added 0.86%	3,732 $841,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $6,921 - $7,702	30 Added 0.82%	3,700 $900,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $8,990 - $9,945	41 Added 1.13%	3,670 $888,000
Q4 2021 Jun 02, 2022	BUY	$198.88 - $227.6 $27,644 - $31,636	139 Added 3.98%	3,629 $816,000
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $82,734 - $94,681	-416 Reduced 10.65%	3,490 $785,000
Q3 2021 Jun 02, 2022	BUY	$212.27 - $248.7 $29,505 - $34,569	139 Added 3.69%	3,906 $831,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $40,968 - $47,999	-193 Reduced 4.87%	3,767 $801,000
Q2 2021 Jun 02, 2022	BUY	$233.58 - $259.14 $32,467 - $36,020	139 Added 3.64%	3,960 $965,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $2.89 Million - $3.21 Million	-12,378 Reduced 76.41%	3,821 $931,000
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $3.77 Million - $4.4 Million	-17,002 Reduced 51.21%	16,199 $4.03 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $2.65 Million - $3.16 Million	12,254 Added 58.5%	33,201 $7.63 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $22,291 - $24,790	-95 Reduced 0.45%	20,947 $5.32 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $2.24 Million - $2.75 Million	-11,335 Reduced 35.01%	21,042 $4.96 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $544,350 - $721,957	-2,987 Reduced 8.45%	32,377 $6.56 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $46,545 - $59,827	-246 Reduced 0.69%	35,364 $8.53 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $269,522 - $322,943	-1,548 Reduced 4.17%	35,610 $6.89 Million
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $3,667 - $4,299	22 Added 0.06%	37,158 $6.85 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $129,864 - $146,385	-718 Reduced 1.9%	37,136 $7.06 Million
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $265,459 - $309,876	1,488 Added 4.09%	37,854 $7.37 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $831,766 - $937,707	-4,489 Reduced 10.99%	36,366 $7.54 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $40,350 - $45,321	243 Added 0.6%	40,855 $7.54 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $421,372 - $492,426	-2,487 Reduced 5.77%	40,612 $6.92 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.14 Million - $1.27 Million	6,753 Added 18.58%	43,099 $7.5 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $898,012 - $1.03 Million	-5,368 Reduced 12.87%	36,346 $6.78 Million
Q2 2017 Aug 09, 2017	BUY	N/A	41,714	41,714 $7.18 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Account

Sheaff Brock Investment Advisors, LLC Amgen Inc Transaction History